Therapeutic Efficacy of Neoadjuvant Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors

Neoadjuvant PRRT appears to be an effective therapeutic strategy for patients with NETs, particularly by reducing tumor size and stage in borderline resectable or unresectable cases. These findings suggest that neoadjuvant PRRT represents a promising option to facilitate surgical resection and improve outcomes in NET patients.